HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michele T Yip-Schneider Selected Research

2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluoro- 5- bromobenzamide

6/2009Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
1/2006The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michele T Yip-Schneider Research Topics

Disease

19Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 03/2003
19Neoplasms (Cancer)
01/2023 - 03/2003
11Pancreatic Cyst
02/2021 - 02/2008
8Neoplasms, Cystic, Mucinous, and Serous
02/2021 - 03/2011
7Hepatocellular Carcinoma (Hepatoma)
04/2010 - 03/2004
6Carcinogenesis
01/2021 - 01/2002
6Adenocarcinoma
01/2020 - 01/2002
4Cysts
02/2021 - 04/2014
2Neoplasm Metastasis (Metastasis)
04/2013 - 10/2008
1Insulin Resistance
01/2019
1Pancreatitis
01/2019
1Margins of Excision
01/2019
1Chronic Pancreatitis
10/2017
1Pancreatic Diseases (Pancreatic Disease)
03/2012
1Cholangiocarcinoma
11/2009
1Fibrosis (Cirrhosis)
06/2009
1Hepatitis
06/2009
1Lung Neoplasms (Lung Cancer)
11/2007
1Liver Neoplasms (Liver Cancer)
01/2006
1Transitional Cell Carcinoma
01/2002
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2002

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
02/2021 - 04/2014
7Sulindac (Copal)FDA LinkGeneric
01/2013 - 03/2003
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2010 - 11/2003
6Proteins (Proteins, Gene)FDA Link
02/2021 - 01/2002
5NF-kappa B (NF-kB)IBA
04/2013 - 04/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2021 - 04/2014
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2017 - 03/2003
4parthenolideIBA
12/2013 - 04/2005
4GemcitabineFDA Link
04/2013 - 02/2008
4CarcinogensIBA
11/2009 - 06/2006
3Carcinoembryonic AntigenIBA
01/2021 - 05/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2018
3Dinoprostone (PGE2)FDA Link
01/2019 - 06/2006
3Transcription Factors (Transcription Factor)IBA
04/2013 - 04/2005
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2013 - 06/2006
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2018
2EnzymesIBA
01/2019 - 01/2002
2Indicators and Reagents (Reagents)IBA
10/2017 - 02/2008
2LC-1 compoundIBA
07/2012 - 10/2008
2mirdametinibIBA
04/2010 - 01/2008
2Transforming Growth Factor alpha (TGF-alpha)IBA
06/2009 - 01/2008
2Mitogen-Activated Protein KinasesIBA
06/2009 - 03/2004
2U 0126 (UO 126)IBA
06/2009 - 11/2003
22- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluoro- 5- bromobenzamideIBA
06/2009 - 01/2006
2Celecoxib (Celebrex)FDA Link
10/2008 - 11/2007
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2008 - 06/2006
2ProstaglandinsIBA
02/2008 - 11/2007
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2007 - 06/2006
1MicroRNAs (MicroRNA)IBA
01/2023
1human VEGFA proteinIBA
02/2021
1Protein Isoforms (Isoforms)IBA
02/2021
1Codon (Codons)IBA
01/2021
1MucinsIBA
01/2021
1AmylasesFDA Link
01/2021
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2020
1Glycoproteins (Glycoprotein)IBA
01/2019
1ImmunosorbentsIBA
01/2019
1Inosine Monophosphate (IMP)IBA
01/2019
1InterleukinsIBA
01/2019
1CarbohydratesIBA
01/2019
1AntigensIBA
01/2019
1Branched-Chain Amino AcidsIBA
01/2019
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2019
1LeptinIBA
01/2019
1gastricsinIBA
08/2017
1Peptide Hydrolases (Proteases)FDA Link
08/2017
1Cathepsin EIBA
08/2017
1Aspartic Acid ProteasesIBA
08/2017
1Circulating Tumor DNAIBA
01/2017
1EstersIBA
10/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2014
1Dihydrotachysterol (AT 10)IBA
12/2013
1ProteomeIBA
03/2012
1SecretinFDA Link
03/2012
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
12/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2011
1Ethanol (Ethyl Alcohol)IBA
06/2009
1Mitogen-Activated Protein Kinase 3IBA
06/2009
11,3-butadiene (divinyl)IBA
06/2009
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2009
1lymphotactinIBA
10/2008
1Antineoplastic Agents (Antineoplastics)IBA
10/2008
1Prostaglandins EIBA
02/2008
1Cyclin D1IBA
06/2007
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
06/2006
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
03/2003
1Phosphatidylinositols (Phosphatidylinositol)IBA
03/2003

Therapy/Procedure

3Chemoprevention
04/2013 - 01/2008
3Drug Therapy (Chemotherapy)
04/2013 - 06/2006
3Therapeutics
06/2007 - 03/2003
1Pancreatectomy
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
06/2007
1Oral Administration
06/2006